Tennessee Plaintiff Files Actos Lawsuit in Illinois Court

Staff Writer | March 30th, 2012

On March 9, 2012, Charles Edward White, a resident of Tennessee, filed an Actos side effects lawsuit in the Circuit Court of Cook County, Illinois. According to his Actos lawyer, the plaintiff was diagnosed with Actos bladder cancer as a direct result of taking the diabetes medication. White asks the court for compensation of his injuries.

Plaintiff suffers from Actos bladder cancer

Type II diabetes, the most common form of diabetes, occurs when the body does not produce sufficient insulin and does not use efficiently the insulin it does produce. Enter Actos, an insulin-sensitizing medication first approved by the U.S. Food and Drug Administration (FDA) in July 1999 to treat type II diabetes.

However, according to White’s Actos lawyer, the drug does more than just stabilize a patient’s insulin levels: “As a result of the defective nature of Actos, persons who were prescribed and ingested Actos for more than twelve months, including Plaintiff, were at increased risk for developing bladder cancer, [and] have suffered … from bladder cancer.”

Actos side effects lawsuit claims wanton malice

A principal allegation in White’s lawsuit is that Takeda “willfully, wantonly and with malice” concealed their knowledge of bladder cancer risks, specifically in patients who took the drug for more than 12 months.

The plaintiff’s Actos lawyer cites several studies and other evidence to support this allegation, among them a two-year carcinogenicity study that was conducted prior to Actos’ FDA approval, which indicated that male rats receiving Actos developed drug-induced tumors.

In 2005, results from the PROspective PioglitAzone Clinical Trial in MacroVascular Events (PROactive) study indicated that there was a significantly higher risk of bladder cancer in patients taking Actos than in those taking similar drugs, yet neither Takeda nor the researchers publish these findings. White’s Actos lawyer contends that the plaintiff developed Actos cancer as a proximate result of these acts and omissions.

Actos lawyer requests compensation

On or around February 2007, the plaintiff was prescribed and began taking Actos for long-term maintenance of his Type II diabetes. He stopped taking the drug around July 2009, but it was already too late: in October 2009, White alleges that he was diagnosed with Actos cancer.

Prior to June 2011, the plaintiff states he was unaware of the risk of bladder cancer, but had he understood the possibility, he would never have taken Actos. He claims permanent and severe injuries, as well as ongoing requirements for medical care and treatment.

David Eisbrouch is an experienced trial attorney representing people and families who have suffered serious, life changing injuries due to negligence. Since establishing Eisbrouch Marsh, LLC, we have focused the firm’s resources on helping people recover money for ... read more

It should come as no surprise to an Actos lawyer that another TZD drug is back in the spotlight after exposing patients to dangerous side effects. But this time, the risk is less concerned with heart failure and more focused on a certain type of cancer. Shortly after the FDA released a June 15 warning regarding Actos bladder cancer, we began receiving calls to our Actos lawsuit phone number.
Callers who have taken the type-2 diabetes drug Actos, particularly those who have taken it in high doses for more than a year, express increasing concern that they have been exposed to a risk of which they were not previously aware. Although this particular Actos side effect has been the subject of ongoing medical investigation for some time, other recent events both here and abroad have further sparked the attention of consumers and patients worldwide. As a result, many are seeking... Read more from our lead Actos Lawyer

ATTORNEY ADVERTISING. Prior results do not guarantee similar outcome. Requesting a free legal consultation does not create an attorney-client relationship and you are not considered a client until a representation agreement has been signed and your case has been accepted.